Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 3, 2005, Pages 541-551

  Bouchard, B A ^a   Williams, J L ^a   Meisler, N T ^a   Long, M W ^a   Tracy, Paula B ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Clathrin; Endocytosis; Factor V; Megakaryocyte; Platelet; Receptor

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 9; CLATHRIN; FIBRINOGEN; PHORBOL ESTER;

ARTICLE; CD34 SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; ENDOCYTOSIS; EX VIVO STUDY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEMBRANE BINDING; PRIORITY JOURNAL; THROMBOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE; CYTOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; ULTRASTRUCTURE;

CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE; CELLS, CULTURED; CLATHRIN; ENDOCYTOSIS; FACTOR V; HUMANS; MEGAKARYOCYTES; PROTEIN BINDING;

EID: 23944447695     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01190.x     Document Type: Article

References (55)

1. Sporn LA, Chavin SI, Marder VJ, Wagner DD. Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 1985; 76: 1102-6.
2. Sitar G, Borroni R, Pesce G. Synthesis of thrombospondin and glycoprotein IIb-IIIa by a purified megakaryocyte human bone marrow culture. Haematologica 1986; 71: 389-93.
3. Konkle BA, Schick PK, He X, Liu RJ, Mazur EM. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288. Arterioscler Thromb 1993; 13: 669-74.
4. Hill SSSG, Joshua P, Ribau J, Austin RC, Podor TJ. Differential mechanisms targeting type I plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line. Blood 1996; 87: 5061-73.
5. Roussi JDL, Sigman J, Vaiman M, Pignaud G, Bonneau M, Martin Cramer E. Absence of incorporation of plasma von Willebrand factor into porcine platelet α-granules. Br J Haematol 1995; 90: 661-8.
6. Cramer EM, Debili N, Martin JF, Gladwin AM, Breton-Gorius J, Harrison P, Savidge GF, Vainchenker W. Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes. Blood 1989; 73: 1123-9.
7. Handagama P, Scarborough RM, Shuman MA, Bainton DF. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa) [published erratum appears in Blood 1993; 82 (9): 2936]. Blood 1993; 82: 135-8.
8. Louache F, Debili N, Cramer E, Breton-Gorius J, Vainchenker W. Fibrinogen is not synthesized by human megakaryocytes. Blood 1991; 77: 311-16.
9. Podolak-Dawidziak M, Hancock V, Lelchuk R, Kotlarek-Haus S, Martin JF. The expression of mRNA for fibrinogen in megakaryocytes isolated from patients with T-cell lymphoma. Br J Haematol 1995; 91: 362-6.
10. Poujol C, Nurden AT, Nurden P. Ultrastructural analysis of the distribution of the vitronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the alpha-granule membrane. Br J Haematol 1997; 96: 823-35.
11. Camire RM, Pollak ES, Kaushansky K, Tracy PB. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998; 92: 3035-41.
12. Christella M, Thomassen LG, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologica 2003; 88: 1150-6.
13. Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost 2005; 3: 450-6.
14. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24.
15. Mazzorana M, Baffet G, Kneip B, Launois B, Guguen-Guillouzo C. Expression of coagulation factor V gene by normal adult human hepatocytes in primary culture. Br J Haematol 1991; 78: 229-35.
16. Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 2004; 279: 2383-93.
17. Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990; 265: 17132-40.
18. Monkovic DD, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990; 29: 1118-28.
19. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-80.
20. Camire RM, Kalafatis M, Cushman M, Tracy RP, Mann KG, Tracy PB. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem 1995; 270: 20794-800.
21. Conlon SJ, Camire RM, Kalafatis M, Tracy PB. Cleavage of platelet-derived factor Va by plasmin results in increased and sustained co-factor activity on the thrombin-activated platelet surface. Thromb Haemost 1997; 77: 2507a.
22. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood 1998; 91: 2818-29.
23. Tracy PB, Mann KG. Abnormal formation of the prothrombinase complex: factor V deficiency and related disorders. Hum Pathol 1987; 18: 162-9.
24. Nesheim ME, Nichols WL, Cole TL, Houston JG, Schenk RB, Mann KG, Bowie EJ. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 1986; 77: 405-15.
25. Yang TL, Pipe SW, Yang A, Ginsburg D. Biosynthetic origin and functional significance of murine platelet factor V. Blood 2003; 102: 2851-5.
26. Sun H, Yang TL, Yang A, Wang X, Ginsburg D. The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis. Blood 2003; 102: 2856-61.
27. Chiu HC, Schick PK, Colman RW. Biosynthesis of factor V in isolated guinea pig megakaryocytes. J Clin Invest 1985; 75: 339-46.
28. Tracy PB, Peterson JM, Nesheim ME, McDuffie FC, Mann KG. Interaction of coagulation factor V and factor Va with platelets. J Biol Chem 1979; 254: 10354-61.
29. Cerveny TJ, Fass DN, Mann KG. Synthesis of coagulation factor V by cultured aortic endothelium. Blood 1984; 63: 1467-74.
30. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-50.
31. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6.
32. Katzmann JA, Nesheim ME, Hibbard LS, Mann KG. Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 162-6.
33. Straughn W 3rd, Wagner RH. A simple method for preparing fibrinogen. Thromb Diath Haemorrh 1966; 16: 198-206.
34. Williams JL, Pipia GG, Datta NS, Long MW. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood 1998; 91: 4118-26.
35. Taniguchi Y, London R, Schinkmann K, Jiang S, Avraham H. The receptor protein tyrosine phosphatase, PTP-RO, is upregulated during megakaryocyte differentiation and is associated with the c-Kit receptor. Blood 1999; 94: 539-49.
36. Fugman DA, Witte DP, Jones CL, Aronow BJ, Lieberman MA. In vitro establishment and characterization of a human megakaryoblastic cell line. Blood 1990; 75: 1252.
37. Chuang JL, Schleef RR. Adenovirus-mediated expression and packaging of tissue-type plasminogen activator in megakaryocytic cells. Thromb Haemost 2001; 85: 1079-85.
38. Nagano T, Kishimoto Y, Kimura T, Yasunaga K, Adachi M, Ryo R, Sato T et al. Ultrastructural analysis of a human megakaryocytic leukemia cell line (CMK11-5) in response to platelet agonists. lnt J Hematol 1993; 57: 73-80.
39. Bouchard BA, Thanassi NM, Tracy PB. Factor V endocytosed and retained by megakaryocytes is proteolytically processed by an intracellular protease to form the platelet-derived factor V pool. J Thrombosis Hemostasis 2003; 1: P1335.
40. Nagano T, Taniguchi H, Hamamoto K. Ultrastructural analysis of incorporation into organelles of CMK cells. J Clin Electron Microscopy 1989; 22: 5-6.
41. Ogura M, Morishima Y, Okumura M, Hotta T, Takamoto S, Ohno R, Hirabayashi N, Nagura H, Saito N. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-O1s) by phorbol diesters. Blood 1988; 72: 49-60.
42. Harrison P, Cramer EM. Platelet α-granules. Blood Rev, 1993: 52-62.
43. Bayer N, Schober D, Huttinger M, Blaas D, Fuchs R. Inhibition of clathrin-dependent endocytosis has multiple effects on HRV2 cell entry. J Biol Chem 2000; 276: 3952-62.
44. Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 1989; 108: 389-400.
45. Klinger MH, Kluter H. Immunocytochemical colocalization of adhesive proteins with clathrin in human blood platelets. Further evidence for coated vesicle-mediated transport of von Willebrand factor, fibrinogen and fibronectin. Cell Tissue Res 1995; 279: 453-7.
46. Barlic J, Khandaker MH, Mahon E, Andrews J, DeVries ME, Mitchell GB, Rahimpour R, Tan CM, Ferguson SS, Kelvin DJ. β-arrestins regulate interleukin-8-induced CXCR1 internalization. J Biol Chem 1999; 274: 16287-94.
47. Cao H, Orth JD, Chen J, Weller SG, Heuser JE, McNiven MA. Cortactin is a component of clathrin-coated pits and participates in receptor-mediated endocytosis. Mol Cell Biol 2003; 23: 2162-70.
48. Teo M, Tan L, Lim L, Manser E. The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J Biol Chem 2001; 276: 18392-8.
49. Wei ML, Bonzelius F, Scully RM, Kelly RB, Herman GA. GLUT4 and transferrin receptor are differentially sorted along the endocytic pathway in CHO cells. J Cell Biol 1998; 140: 565-75.
50. Memmo LM, McKeown-Longo P. The alphavbeta5 integrin functions as an endocytic receptor for vitronectin. J Cell Sci 1998; 111: 425-33.
51. Giampaolo A, Vulcano F, Macioce G, Mattia G, Barca A, Milazzo L, Orlando M, Hassan HJ. Factor V expression in human in vitro developed megakaryocytes. Thromb Haemost 2001; 86: 542a.
52. Veljkovic D, Cramer EM, Alimardani G, Fichelson S, Masse JM, Hayward CPM. Studies of alpha-granule proteins in cultured human megakaryocytes. Thromb Haemost 2003; 90: 844-52.
53. Gewirtz AM, Keefer M, Doshi K, Annamalai AE, Chiu HC, Colman RW. Biology of human megakaryocyte factor V. Blood 1986; 67: 1639-48.
54. Gewirtz AM, Shapiro C, Shen YM, Boyd R, Colman RW. Cellular and molecular regulation of factor V expression in human megakaryocytes. J Cell Phys 1992; 153: 277-87.
55. Heijnen HFG, Debili N, Vainchencker W, Breton-Gorius J, Geuze HJ, Sixma JJ. Multivesicular bodies are an intermediate stage in the formation of platelet α-granules. Blood 1998; 91: 2313-25.